These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26479518)

  • 21. Pharmacogenetics-based therapeutic recommendations--ready for clinical practice?
    Kirchheiner J; Fuhr U; Brockmöller J
    Nat Rev Drug Discov; 2005 Aug; 4(8):639-47. PubMed ID: 16056390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 23. Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.
    Maisano Delser P; Fuselli S
    Hum Genet; 2013 May; 132(5):563-77. PubMed ID: 23354977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; Turner AJ; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2024 Oct; 26(10):851-863. PubMed ID: 39032821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perception of personalized medicine, pharmacogenomics, and genetic testing among undergraduates in Hong Kong.
    Cheung NYC; Fung JLF; Ng YNC; Wong WHS; Chung CCY; Mak CCY; Chung BHY
    Hum Genomics; 2021 Aug; 15(1):54. PubMed ID: 34407885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetic profiling via genome sequencing in children with medical complexity.
    Pan A; Scodellaro S; Khan T; Ushcatz I; Wu W; Curtis M; Cohen E; Cohn RD; Hayeems RZ; Meyn MS; Orkin J; Otal J; Reuter MS; Walker S; Scherer SW; Marshall CR; Cohn I; Costain G
    Pediatr Res; 2023 Mar; 93(4):905-910. PubMed ID: 36167815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Previous Genetic Counseling and Objective Numeracy on Accurate Interpretation of a Pharmacogenetics Test Report.
    Drelles K; Pilarski R; Manickam K; Shoben AB; Toland AE
    Public Health Genomics; 2021; 24(1-2):26-32. PubMed ID: 33445171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system.
    Danahey K; Borden BA; Furner B; Yukman P; Hussain S; Saner D; Volchenboum SL; Ratain MJ; O'Donnell PH
    J Biomed Inform; 2017 Nov; 75():110-121. PubMed ID: 28963061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.
    Evans BJ
    Clin Pharmacol Ther; 2010 Dec; 88(6):749-51. PubMed ID: 21081943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics.
    Li B; Whirl-Carrillo M; Wright MW; Babb L; Rehm HL; Klein TE
    Pac Symp Biocomput; 2022; 27():385-396. PubMed ID: 34890165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
    Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
    Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials.
    Fabbri C; Zohar J; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():36-44. PubMed ID: 29777729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comfort with Pharmacogenetic Testing Amongst Pediatric Oncology Providers and Their Patients.
    Mowbray C; Turner J; Gai J; Jacobs S
    J Pediatr Hematol Oncol Nurs; 2022; 39(3):168-177. PubMed ID: 35467433
    [No Abstract]   [Full Text] [Related]  

  • 35. Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center.
    Pasternak AL; Ward KM; Ateya MB; Choe HM; Thompson AN; Clark JS; Ellingrod V
    J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33023029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
    Duarte JD; Dalton R; Elchynski AL; Smith DM; Cicali EJ; Lee JC; Duong BQ; Petry NJ; Aquilante CL; Beitelshees AL; Empey PE; Johnson JA; Obeng AO; Pasternak AL; Pratt VM; Ramsey LB; Tuteja S; Van Driest SL; Wiisanen K; Hicks JK; Cavallari LH;
    Genet Med; 2021 Dec; 23(12):2335-2341. PubMed ID: 34282303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized medicine into health national services: barriers and potentialities.
    Rodríguez Vicente AE; Herrero Cervera MJ; Bernal ML; Rojas L; Peiró AM
    Drug Metab Pers Ther; 2018 Dec; 33(4):159-163. PubMed ID: 30391933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
    Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacogenetic testing: time for clinical practice guidelines.
    Amstutz U; Carleton BC
    Clin Pharmacol Ther; 2011 Jun; 89(6):924-7. PubMed ID: 21508939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.